Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Klimaktoplan is a non-hormonal, complex homeopathic medicine formulated for the relief of menopausal (climacteric) symptoms, such as hot flashes, increased sweating, palpitations, dizziness, itching, sleep disturbances, and nervous tension. It is manufactured by Deutsche Homöopathie-Union (DHU) and distributed or marketed in various regions by partners like Alpen Pharma and LB Abnoba. The formulation consists of four active homeopathic components: Cimicifuga racemosa (black cohosh), Sepia officinalis (common cuttlefish), Strychnos ignatia (St. Ignatius bean), and Sanguinaria canadensis (bloodroot). These ingredients work synergistically to normalize hormonal balance, regulate autonomic nervous system functions, and alleviate psycho-emotional symptoms associated with menopause.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Klimaktoplan.